EUVIMEDEUVIMED entdecken
Open Access

Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple Etiologies

Nathan C Bahr iD, Caleb P Skipper, Kathy Huppler-Hullsiek, Kenneth Ssebambulidde, Bozena M Morawski, Nicole W Engen, Edwin Nuwagira, Carson M Quinn, Prashanth S Ramachandran, Emily E Evans, Sarah M Lofgren, Mahsa Abassi und 5 weitere

Clinical Infectious Diseases · 21.03.2023 · 76 (6) · 1080-1087

DOI: 10.1093/cid/ciac853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 28.10.2022. Verfasst von Nathan C Bahr und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, AIDS-Related Opportunistic Infections, HIV Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NINDS NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cryptococcal meningitis is a common cause of AIDS-related mortality. Although symptom recurrence after initial treatment is common, the etiology is often difficult to decipher. We sought to summarize characteristics, etiologies, and outcomes among persons with second-episode symptomatic recurrence.

Methods

We prospectively enrolled Ugandans with cryptococcal meningitis and obtained patient characteristics, antiretroviral therapy (ART) and cryptococcosis histories, clinical outcomes, and cerebrospinal fluid (CSF) analysis results. We independently adjudicated cases of second-episode meningitis to categorize patients as (1) microbiological relapse, (2) paradoxical immune reconstitution inflammatory syndrome (IRIS), (3) persistent elevated intracranial pressure (ICP) only, or (4) persistent symptoms only, along with controls of primary cryptococcal meningitis. We compared groups with chi-square or Kruskal-Wallis tests as appropriate.

Results

724 participants were included (n = 607 primary episode, 81 relapse, 28 paradoxical IRIS, 2 persistently elevated ICP, 6 persistent symptoms). Participants with culture-positive relapse had lower CD4 (25 cells/μL; IQR: 9–76) and lower CSF white blood cell (WBC; 4 cells/μL; IQR: 4–85) counts than paradoxical IRIS (CD4: 78 cells/μL; IQR: 47–142; WBC: 45 cells/μL; IQR: 8–128). Among those with CSF WBC <5 cells/μL, 86% (43/50) had relapse. Among those with CD4 counts <50 cells/μL, 91% (39/43) had relapse. Eighteen-week mortality (from current symptom onset) was 47% among first episodes of cryptococcal meningitis, 31% in culture-positive relapses, and 14% in paradoxical IRIS.

Conclusions

Poor immune reconstitution was noted more often in relapse than IRIS as evidenced by lower CSF WBC and blood CD4 counts. These easily obtained laboratory values should prompt initiation of antifungal treatment while awaiting culture results. Clinical Trials Registration NCT01802385.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningitis, CryptococcalAIDS-Related Opportunistic InfectionsHIV InfectionsHumansAntifungal AgentsRecurrence

Stichwörter der Autor:innen

cryptococcal meningitiscryptococcosisimmune reconstitution inflammatory syndromemeningitisrelapse

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
  • Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
  • Infectious Diseases Institute, Makerere University, Kampala, Uganda.
  • Cancer Data Registry of Idaho, Idaho Hospital Association, Boise, Idaho, USA.
  • Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.

ORCID-Profile: Nathan C Bahr

Förderung

  • NIAID NIH HHS
  • NINDS NIH HHS
  • NCATS NIH HHS
  • FIC NIH HHS
  • NCI NIH HHS
  • NIMH NIH HHS
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Bahr, N. C., Skipper, C. P., Huppler-Hullsiek, K., Ssebambulidde, K., Morawski, B. M., Engen, N. W., Nuwagira, E., Quinn, C. M., Ramachandran, P. S., Evans, E. E., Lofgren, S. M., Abassi, M., Muzoora, C., Wilson, M. R., Meya, D. B., Rhein, J., & Boulware, D. R. (2023). Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple Etiologies. Clinical Infectious Diseases, 76(6), 1080-1087. https://doi.org/10.1093/cid/ciac853

Vancouver

Bahr NC, Skipper CP, Huppler-Hullsiek K, Ssebambulidde K, Morawski BM, Engen NW, et al. Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple Etiologies. Clinical Infectious Diseases. 2023;76(6):1080-1087. doi:10.1093/cid/ciac853

BibTeX
@article{Bahr2023,
  author = {Bahr, Nathan C and Skipper, Caleb P and Huppler-Hullsiek, Kathy and Ssebambulidde, Kenneth and Morawski, Bozena M and Engen, Nicole W and Nuwagira, Edwin and Quinn, Carson M and Ramachandran, Prashanth S and Evans, Emily E and Lofgren, Sarah M and Abassi, Mahsa and Muzoora, Conrad and Wilson, Michael R and Meya, David B and Rhein, Joshua and Boulware, David R},
  title = {Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple Etiologies},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {6},
  pages = {1080--1087},
  doi = {10.1093/cid/ciac853}
}
Kostenlos starten →